141 related articles for article (PubMed ID: 8943399)
21. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.
Raddrizzani L; Sturniolo T; Guenot J; Bono E; Gallazzi F; Nagy ZA; Sinigaglia F; Hammer J
J Immunol; 1997 Jul; 159(2):703-11. PubMed ID: 9218585
[TBL] [Abstract][Full Text] [Related]
22. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
Costantini S; Rossi M; Colonna G; Facchiano AM
J Mol Graph Model; 2005 Apr; 23(5):419-31. PubMed ID: 15781184
[TBL] [Abstract][Full Text] [Related]
23. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner.
Gautam AM; Yang M; Milburn PJ; Baker R; Bhatnagar A; McCluskey J; Boston T
J Immunol; 1997 Sep; 159(6):2782-8. PubMed ID: 9300699
[TBL] [Abstract][Full Text] [Related]
24. The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection.
Suri A; Unanue ER
Adv Immunol; 2005; 88():235-65. PubMed ID: 16227092
[TBL] [Abstract][Full Text] [Related]
25. CLIP-region mediated interaction of Invariant chain with MHC class I molecules.
Powis SJ
FEBS Lett; 2006 May; 580(13):3112-6. PubMed ID: 16678175
[TBL] [Abstract][Full Text] [Related]
26. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.
Busch R; Doebele RC; von Scheven E; Fahrni J; Mellins ED
J Immunol; 1998 Jan; 160(2):734-43. PubMed ID: 9551909
[TBL] [Abstract][Full Text] [Related]
27. Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing.
Verreck FA; van de Poel A; Termijtelen A; Amons R; Drijfhout JW; Koning F
Eur J Immunol; 1994 Feb; 24(2):375-9. PubMed ID: 8299686
[TBL] [Abstract][Full Text] [Related]
28. Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM.
Belmares MP; Busch R; Mellins ED; McConnell HM
Biochemistry; 2003 Jan; 42(3):838-47. PubMed ID: 12534297
[TBL] [Abstract][Full Text] [Related]
29. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
[TBL] [Abstract][Full Text] [Related]
30. Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.
Stumptner P; Benaroch P
EMBO J; 1997 Oct; 16(19):5807-18. PubMed ID: 9312039
[TBL] [Abstract][Full Text] [Related]
31. Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes.
McFarland BJ; Beeson C; Sant AJ
J Immunol; 1999 Oct; 163(7):3567-71. PubMed ID: 10490947
[TBL] [Abstract][Full Text] [Related]
32. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
Schafer PH; Green JM; Malapati S; Gu L; Pierce SK
J Immunol; 1996 Dec; 157(12):5487-95. PubMed ID: 8955198
[TBL] [Abstract][Full Text] [Related]
33. A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak.
Nelson CA; Viner NJ; Young SP; Petzold SJ; Unanue ER
J Immunol; 1996 Jul; 157(2):755-62. PubMed ID: 8752926
[TBL] [Abstract][Full Text] [Related]
34. A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus.
Ettinger RA; Kwok WW
J Immunol; 1998 Mar; 160(5):2365-73. PubMed ID: 9498778
[TBL] [Abstract][Full Text] [Related]
35. Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule.
van de Wal Y; Kooy YM; Drijfhout JW; Amons R; Papadopoulos GK; Koning F
Immunogenetics; 1997; 46(6):484-92. PubMed ID: 9321428
[TBL] [Abstract][Full Text] [Related]
36. [Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases].
Nishimura Y
Nihon Rinsho; 1997 Jun; 55(6):1384-96. PubMed ID: 9200922
[TBL] [Abstract][Full Text] [Related]
37. HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation.
Kwok WW; Kovats S; Thurtle P; Nepom GT
J Immunol; 1993 Mar; 150(6):2263-72. PubMed ID: 8450211
[TBL] [Abstract][Full Text] [Related]
38. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.
Bach JM; Otto H; Nepom GT; Jung G; Cohen H; Timsit J; Boitard C; van Endert PM
J Autoimmun; 1997 Aug; 10(4):375-86. PubMed ID: 9237801
[TBL] [Abstract][Full Text] [Related]
39. Identification of a sequence that mediates promiscuous binding of invariant chain to MHC class II allotypes.
Siebenkotten IM; Carstens C; Koch N
J Immunol; 1998 Apr; 160(7):3355-62. PubMed ID: 9531295
[TBL] [Abstract][Full Text] [Related]
40. Bound peptide-dependent thermal stability of major histocompatibility complex class II molecule I-Ek.
Saito K; Oda M; Sarai A; Azuma T; Kozono H
Biochemistry; 2004 Aug; 43(31):10186-91. PubMed ID: 15287746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
